These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33640906)

  • 1. Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD.
    Dai H; Rachakonda SP; Penack O; Blau IW; Blau O; Radujkovic A; Müller-Tidow C; Dreger P; Kumar R; Luft T
    Blood Cancer J; 2021 Feb; 11(2):42. PubMed ID: 33640906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host Disease.
    Giesen N; Schwarzbich MA; Dischinger K; Becker N; Hummel M; Benner A; Radujkovic A; Müller-Tidow C; Dreger P; Luft T
    Transplantation; 2020 Nov; 104(11):2354-2359. PubMed ID: 31929430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
    Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
    J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease.
    Schroepf S; Kappler R; Brand S; Prell C; Lohse P; Glas J; Hoster E; Helmbrecht J; Ballauff A; Berger M; von Schweinitz D; Koletzko S; Lacher M
    Inflamm Bowel Dis; 2010 Nov; 16(11):1882-90. PubMed ID: 20848514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.
    Kariminia A; Holtan SG; Ivison S; Rozmus J; Hebert MJ; Martin PJ; Lee SJ; Wolff D; Subrt P; Abdossamadi S; Sung S; Storek J; Levings M; Aljurf M; Arora M; Cutler C; Gallagher G; Kuruvilla J; Lipton J; Nevill TJ; Newell LF; Panzarella T; Pidala J; Popradi G; Szwajcer D; Tay J; Toze CL; Walker I; Couban S; Storer BE; Schultz KR
    Blood; 2016 Jun; 127(24):3082-91. PubMed ID: 27020088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD.
    Croudace JE; Inman CF; Abbotts BE; Nagra S; Nunnick J; Mahendra P; Craddock C; Malladi R; Moss PA
    Blood; 2012 Nov; 120(20):4246-55. PubMed ID: 23012327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.
    Kitko CL; Levine JE; Storer BE; Chai X; Fox DA; Braun TM; Couriel DR; Martin PJ; Flowers ME; Hansen JA; Chang L; Conlon M; Fiema BJ; Morgan R; Pongtornpipat P; Lamiman K; Ferrara JL; Lee SJ; Paczesny S
    Blood; 2014 Jan; 123(5):786-93. PubMed ID: 24363401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes Simplex Virus Type 2 Infection-Induced Expression of CXCR3 Ligands Promotes CD4
    Zhang M; Deng X; Guan X; Geng L; Fu M; Zhang B; Chen R; Hu H; Hu K; Zhang D; Li M; Liu Y; Gong S; Hu Q
    Front Immunol; 2018; 9():2932. PubMed ID: 30619292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Nucleotide Polymorphisms Within the Thrombomodulin Gene (THBD) Predict Mortality in Patients With Graft-Versus-Host Disease.
    Rachakonda SP; Penack O; Dietrich S; Blau O; Blau IW; Radujkovic A; Isermann B; Ho AD; Uharek L; Dreger P; Kumar R; Luft T
    J Clin Oncol; 2014 Oct; 32(30):3421-7. PubMed ID: 25225421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker Panel for Chronic Graft-Versus-Host Disease.
    Yu J; Storer BE; Kushekhar K; Abu Zaid M; Zhang Q; Gafken PR; Ogata Y; Martin PJ; Flowers ME; Hansen JA; Arora M; Cutler C; Jagasia M; Pidala J; Hamilton BK; Chen GL; Pusic I; Lee SJ; Paczesny S
    J Clin Oncol; 2016 Aug; 34(22):2583-90. PubMed ID: 27217465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
    Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J
    Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
    Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
    J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1β induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration.
    Guo YC; Chiu YH; Chen CP; Wang HS
    Stem Cell Res Ther; 2018 Oct; 9(1):281. PubMed ID: 30359318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cysteine-X-cysteine motif chemokine ligands 9, 10, and 11, their receptor CXCR3, and their possible role on the recruitment of immune cells at the maternal-conceptus interface in pigs.
    Han J; Gu MJ; Yoo I; Choi Y; Jang H; Kim M; Yun CH; Ka H
    Biol Reprod; 2017 Jul; 97(1):69-80. PubMed ID: 28859287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies.
    Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Zychowska M; Mika J
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3418-3437. PubMed ID: 30076959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphism of CC chemokine ligand 5 promoter gene in recipients may predict the risk of chronic graft-versus-host disease and its severity after allogeneic transplantation.
    Kim DH; Jung HD; Lee NY; Sohn SK
    Transplantation; 2007 Oct; 84(7):917-25. PubMed ID: 17984846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
    Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
    Front Immunol; 2018; 9():109. PubMed ID: 29456530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.
    Partanen J; Hyvärinen K; Bickeböller H; Bogunia-Kubik K; Crossland RE; Ivanova M; Perutelli F; Dressel R
    Front Immunol; 2020; 11():575492. PubMed ID: 33193367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.